Delivery Order SPE2DB22D2007-SPE2DB23FJ6EY
Award Date 9/18/23
Potential Completion Date 9/19/23
Potential Value $19
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,540 delivery order to Amerisourcebergen Drug Corporation for 4562262652, methotrexate 50 mg/2 ml vials. The firm fixed price order is for delivery of the pharmaceutical product to a location in Conshohocken, Pennsylvania. Performance will take place between September 21-22, 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen is well positioned to fulfill this short-term requirement for...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for the provision of 50 mg/2 ml vials of methotrexate. The firm fixed price order is for a one day period of performance from July 6, 2023 through July 7, 2023 with place of performance in Conshohocken, Pennsylvania. The Defense Logistics Agency supports Department of Defense procurement through contracts and supply chain management for critical medical supplies. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for methotrexate injection vials. The firm fixed price order is being fulfilled under the Prime Vendor Pharmaceutical program and will provide 4561707418 units of methotrexate 50 mg/2 ml vials from Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for the provision of 4562331305, methotrexate 50 mg/2 ml vials. The firm fixed price order is for delivery to a location in Conshohocken, Pennsylvania and has a performance period spanning September 27 through September 28, 2023. Amerisourcebergen will supply the pharmaceutical products to the DLA, the logistics combat support agency of the Department of Defense, in support of its mission to...
- The Defense Logistics Agency awarded a $9,910 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562138340, methotrexate in 1 gram/40 ml vials. The single day contract has a period of performance from September 12 through September 13, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceuticals...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for the provision of 4561807098, methotrexate 50 mg/2 ml vials. The firm fixed price order is for delivery to a location in Conshohocken, Pennsylvania between August 14-15, 2023. Amerisourcebergen will supply the pharmaceutical products to the DLA, the logistics combat support agency of the United States Department of Defense, in support of its mission to provide supplies to the military services....
- The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between July 3rd and July 5th, 2023. Amerisourcebergen will supply the methotrexate to the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, in support of its mission to provide supplies to all branches of...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for the provision of 4561500678, methotrexate 50 mg/2 ml vials. The firm fixed price order is to supply 2 ml vials of the drug from Amerisourcebergen's Conshohocken, Pennsylvania location. Performance will take place between July 14-17, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order supports DOD medical readiness and...
- The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate injections. The firm fixed price order is for the delivery of 4562252108 units of methotrexate at 50 mg/2 ml per vial with a total of 2 ml per vial. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania between September 20-21, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. military and other government...
- The Defense Logistics Agency awarded a $18,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562141327 METHOTREXATE 50 MG/2 ML VIAL 2ML. The single day contract runs from September 12-13, 2023, with performance taking place in Conshohocken, Pennsylvania. Amerisourcebergen Corporation will serve as the prime contractor in fulfilling the Defense Logistics Agency's requirements for this pharmaceutical product under an unspecified multiple award contract vehicle. No...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ6EYDelivery Order
The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for methotrexate 50 mg/2 ml vials. The firm fixed price order is for a one day period of performance from September 18-19, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global supply chain and is likely procuring the methotrexate to support treatment of certain cancers or autoimmune disorders at military medical treatment facilities. No subcontractors or set aside designations were identified.
Generated 12/18/23, 1:29 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19 | 9/18/23 |